Transcripts Celemics, Inc.

Stocks

A331920

KR7331920009

Biotechnology & Medical Research

End-of-day quote Korea S.E. 22/09/2026			5-day change	1st Jan Change
10,930.00 ^KRW	+0.64%		-14.54%	+302.58%

06-24	Celemics, Inc. announced that it expects to receive KRW 9.9999956 billion in funding from Cnp Co., Ltd.	CI
05-29	Celemics, Inc. announced that it has received KRW 11.5999945 billion in funding	CI

Transcripts

No results match your criteria

All News Broker Recommendations Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

-40%: Exceptional extension

SEIZE THE OFFER!